Sino Biopharmaceutical Limited
SBMFF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $89 | $59 | $52 | $57 |
| - Cash | $20 | $20 | $10 | $10 |
| + Debt | $12 | $12 | $10 | $10 |
| Enterprise Value | $82 | $52 | $52 | $57 |
| Revenue | $9 | $9 | $6 | $6 |
| % Growth | 0% | 35.3% | 0% | – |
| Gross Profit | $7 | $7 | $5 | $5 |
| % Margin | 82.5% | 82.5% | 80.8% | 80.8% |
| EBITDA | $2 | $2 | $1 | $1 |
| % Margin | 22.4% | 22.4% | 16.7% | 16.8% |
| Net Income | $2 | $2 | $0 | $0 |
| % Margin | 19.3% | 19.3% | 3.7% | 3.7% |
| EPS Diluted | 0.094 | 0.094 | 0.014 | 0.014 |
| % Growth | 0% | 571.4% | 0% | – |
| Operating Cash Flow | $2 | $2 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | $1 | $1 | $0 | $0 |